计算溶液所需的质量、体积或浓度。
Moligand™ 级 ,适用于对基线干扰要求严格的色谱和分析工作流程。
-80℃储存。特低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 11 篇同行评审文献引用。
Z-VAD-FMK是ICE-样蛋白酶(Caspase)的抑制剂。在THP.1细胞中,Z-VAD-FMK可以抑制不同刺激诱导的凋亡。在Jurkat T细胞中,它可以抑制Fas抗原诱导的凋亡。Z-VAD-FMK通过阻断proCPP32活化,而非阻止CPP32的蛋白水解活性从而抑制细胞凋亡。 Z-VAD-FMK抑制不同刺激诱导下的大的DNA片段的形成,且几乎可以完全抑制所有四个刺激诱导下的大的DNA片段的形成。在TLCK存在时,Z-VAD-FMK也可以完全抑制由thapsigargin或cycloheximide诱导的大DNA片段的增加,这与Z-VAD-FMK能够抑制这些处理诱导的凋亡是一致的。这些结果表明Caspase作用于大的DNA片段形成之前的阶段。 Z-VAD-FMK对STS诱导的细胞坏死几乎没有效果,表明Caspase不参与细胞坏死的发生。
序列 Z-Val-Ala-Asp(OMe)-FMK。
Information
In vitro
Z-VAD-FMK\xa0(10 μM) inhibits apoptosis in THP.1 cells. Z-VAD-FMK (10 μM) inhibits activation of PARP protease activity in control THP.1 cell lysates. Z-VAD-FMK\xa0(10 μM) inhibits the processing of CPP32 in intact THP.1 and Jurkat cells. Z-VAD-FMK (50 μM) cotreatment abolishes the apoptotic morphology of camptothecin-treated HL60 cells. Z-VAD-FMK (50 μM) blocks camptothecin-induced DNA fragmentation in HL60 cells. Z-VAD-FMK (50 μM) inhibits cell death following dSMN dsRNA-induced apoptosis in S2 cells. Z-VAD-FMK (50 μM) increases the percentage of transfected cells surviving from 26% to 63% in S2 cells. Z-VAD-FMK (> 100 μM) enhances TNFα-induced neutrophil apoptosis, lower concentrations (1-30 μM) completely blocks TNFα-stimulated apoptosis in human neutrophils. Z-VAD-FMK (10 mM) inhibits apoptosis in anterior stromal keratocytes. Z-VAD-FMK (10 mM) inhibits apoptosis in anterior stromal keratocytes detected with the TUNEL assay.
In vivo
In vivo Z-VAD-FMK administration has been shown previously to be nontoxic and to prevent apoptosis in animal models. Intraperitoneal HK-GBS injection leads to preterm delivery, and pretreatment with Z-VAD-FMK delays preterm delivery in mice. In OVA-sensitized mice,treatment of z-VAD-fmk inhibits allergen-induced leukocyte infiltration. Systemic injection of the pan-caspase inhibitor z-VAD-fmk immediately before OVA challenge reduced inflammatory cell accumulation, mucus hypersecretion, and Th2 cytokine release in OVA-sensitized/challenged mice. Treatment with z-VAD-fmk blocked terminal differentiation of lens epithelial cells and keratinocytes, the differentiation of monocytes into macrophages, and the differentiation of erythroid progenitors. z-VAD-fmk attenuated allergen-induced airway inflammation and hyperreactivity. Treatment with z-VAD-fmk in vivo also prevented subsequent T cell activation ex vivo.
Cell Data
cell lines:Pre-B ALL
Concentrations:50 μM
Incubation Time:48 h
Powder Purity:≥99%
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | Z408507 |